Johns Hopkins Kimmel Cancer Center

Dr Bill Nelson and Dr Chi Dang discuss the impact of circadian rhythms on our metabolism and how researchers are working to utilize this knowledge to improve cancer treatment.

Dr Bill Nelson talks to Dr Andrew Ewald, a cell biologist, about his research into how cancer cells migrate throughout the body and the importance of federal funding to continue building on decades of successful research efforts.

Dr Bill Nelson speaks with Dr Elizabeth Jaffee about her research in cancer vaccines, immunotherapy, and the importance of federal funding in continuing to achieve breakthroughs in cancer treatment.

Dr Bill Nelson talks with Dr Denis Wirtz about his research using CODA, an artificial intelligence platform, to identify and analyze pre-cancerous lesions previously undetected in the pancreas and along the fallopian tubes.

Dr Bill Nelson talks with Dr Ashani Weeraratna about her work in melanoma research, the progress that has been made in treating patients with melanoma, and the importance of federal research funding in finding advancements in treatment for this disease.

Dr Bill Nelson talks to Dr Drew Pardoll about the field of cancer immunology. They explain how cancer cells use 'checkpoints' to turn off immune response and how research efforts at Johns Hopkins to block these checkpoints and re-engage the immune system continue to benefit patients.

Dr Bill Nelson talks with Dr Christine Pratilas, the new Director of Pediatric Oncology at the Johns Hopkins Kimmel Cancer Center, about the care of children with sarcoma and the importance of research funding in discovering new treatments for childhood cancers.

Dr Bill Nelson talks with Dr Christian Meyer about being named the Johns Hopkins Hospital Physician of the Year and treating patients with sarcoma. Read more ➡️  https://bit.ly/3XFAt2R  

Dr Akila Viswanathan speaks with Dr Robert Coppes from The University Medical Center Groningen, Dr David Jaffray from MD Anderson Cancer Center and Dr Helen McNair from The Royal Marsden NHS Foundation Trust Institute of Cancer Research to look ahead to the future of radiation oncology as they discuss how to improve decision making, incorporating artificial intelligence, adapt to new training meth...

Dr Bill Nelson and Dr Vasan Yegnasubramanian review the latest developments in artificial intelligence that are improving cancer treatment. They highlight how radiology and pathology are at the forefront of this technology and explore areas where using AI and data analysis can open more avenues to improving care.

Dr Bill Nelson and Dr Eugene Shenderov discuss the Johns Hopkins Prostate Cancer Multidisciplinary Clinic. They provide an overview, including who participates in reviewing a patient's diagnosis, the schedule of their initial visit and how the team develops a treatment plan. Learn more about the Prostate Cancer Multidisciplinary Clinic here .

In this Cancer Matters podcast, Dr Bill Nelson speaks with Dr Nina Wagner-Johnston about the treatment of lymphoma and the newly opened Cellular Therapy Program at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington DC.  Lymphoma is a blood cancer of the immune system. There are many types of lymphomas with a broad range of aggressiveness and clinical behaviors but the...

In this edition of the  On Target  podcast, Dr Akila Viswanathan speaks with Dr Kristin Redmond about treating brain and spinal tumors and her research on stereotactic body radiation therapy (SBRT). Dr Redmond discusses some ongoing clinical trials using SBRT, a highly precise form of radiation therapy used to treat tumors in while minimizing damage to surrounding areas, that are exploring optimal...

Dr Akila Viswanathan begins a special series focusing on women in radiation oncology at Johns Hopkins in this edition of the On Target podcast. Today she speaks with Dr Ana Kiess about treating patients with prostate cancer and head and neck cancers, her research on the integration of radiopharmaceutical therapies, and the unique challenges women face in academic medicine while balancing leadershi...

October is Breast Cancer Awareness Month. In this episode of the  Cancer Matters podcast, Dr Bill Nelson, Director of the Johns Hopkins Kimmel Cancer Center, speaks with Dr John Fetting and Dr Antonio Wolff about the breast cancer program at Johns Hopkins and the Fetting Fund for Breast Cancer Prevention. The Fetting Fund was inspired by the breast cancer journey of one of Dr Fetting's patients, L...

In this Cancer Matters podcast, Dr Bill Nelson, Director of the Johns Hopkins Kimmel Cancer Center, talks with Beth Blakey and Samantha Schrager from the Cancer Hope Network about their mission providing mentorship to cancer patients, the families of patients and caregivers, and a new partnership with Johns Hopkins. Cancer Hope Network is a peer mentorship program that provides one-on-one support...

September is Sickle Cell Awareness Month. In this Cancer Matters podcast, Dr Bill Nelson, the Director of the Johns Hopkins Kimmel Cancer Center, speaks to Dr Rick Jones and Dr Robert Brodsky about treating sickle cell anemia, an inherited disorder where mutations in the globin gene cause the red blood cells to take on a sickle shape, leading to severe pain and organ damage. They discuss and compa...

In this On Target podcast, Dr Akila Viswanathan, Director of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins Kimmel Cancer Center, speaks with Dr. Deborah Citrin from the National Cancer Institute's Center for Cancer Research and Dr. Zachary Morris from the University of Wisconsin School of Medicine and Public Health for an issue of Seminars in Radiation Oncology focusing...

Dr Akila Viswanathan talks with Dr Robert Griffin from the University of Arkansas for Medical Sciences and Dr Chandan Guha from Montefiore Einstein about a recent edition of Seminars in Radiation Oncology on innovations in physics, biology and clinical translation of spatially fractionated and FLASH radiotherapy.

Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here  

Dr Bill Nelson speaks with Robin Hopkins, the author of What Happens Now? , and Dr Tom Smith about how we can help children comprehend a cancer diagnosis in a loved one and encourage an open dialogue about their feelings and emotions. Download  What Happens Now? for free

Dr Akila Viswanathan speaks with Dr Charles Thomas from the Dartmouth Cancer Center and Dr Ethan Ludmir from the MD Anderson Cancer Center about the design, execution and implementation of clinical trials for Seminars in Radiation Oncology.

Dr Akila Viswanathan talks with Dr Daniel Low, Vice Chair of Medical Physics Research and Innovation at UCLA Health, about MR Guided Radiation Therapy for Seminars in Radiation Oncology.

Dr Akila Viswanathan talks to Dr David Kirsch from the Princess Margaret Cancer Centre/University Health Network about treating soft tissue sarcomas for Seminars in Radiation Oncology.

Dr Bill Nelson talks to Dr Ken Kinzler, cancer researcher and Co-Director of Ludwig Cancer Research at Johns Hopkins, about his work in cancer genetics, the creation of screening tests for early detection and the future of personalized medicine.